Total Funding
71
66
Total FundingCorporate Round raised
Growth Score 71 in past quarter
-10 pts
Heat Score 66 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
46775
NJ Bio provides chemistry and biology services to clients from the biotech and pharmaceutical sectors.
Acquired by 
Suven Pharmaceuticals
- Naresh Jain: Founder, President, CEO, and Chairman of the Board
About the Company
NJ Bio, Inc. is a contract research organization (CRO) and contract development and manufacturing organization (CDMO) specializing in integrated chemistry and biology services for the biotech and pharmaceutical industries. The company offers a wide range of services, including antibody-drug conjugates, protein production, cell-based assays, and
bioanalytical services, all aimed at accelerating product development.